Malaria Treatment Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Treatment (Prescription Medications, Vaccines, Diagnostic Tests, and Others), Drug Type (Branded and Generic), Route of Administration (Oral and Parenteral & Intravenous),

Government and Private Sector's Initiatives to Raise Awareness About Malaria to Drive Global Malaria Treatment Market During 2022-2028

For sample pages and special offers, please visit https://www.thinkingcapsrc.com/reports/1599/malaria-treatment-market

According to our latest study on ""Malaria Treatment Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Treatment, Drug Type, Route of Administration, Distribution Channel, and End User,"" the market is expected to grow from US$ 1,638.27 million in 2021 to US$ 2,291.49 million by 2028; it is estimated to grow at a CAGR of 4.9% from 2022 to 2028. The market growth is primarily attributed to an increasing prevalence of malaria and government and private sector's initiatives to raise awareness about malaria. However, counterfeit antimalarial drugs and subsequent drug resistance are hindering the market growth.

For sample pages and special offers, please visit https://www.thinkingcapsrc.com/reports/1599/malaria-treatment-market

Government and private sector's initiative for raising awareness about malaria act as a standalone factor responsible for the influential growth of the overall malaria treatment market. Malaria awareness campaigns help enhance knowledge regarding the disease and improve behaviors promoting health, along with promoting intersectoral collaboration and social support. The WHO is responsible for coordinating the Global Malaria Programme (GMP) as part of its global efforts to control and eradicate malaria. The program is led by the ""Global Technical Strategy for Malaria 2016-2030,"" which was adopted by the World Health Assembly in May 2015 and was further restructured in 2021. The WHO observes 25 April as World Malaria Day every year to highlight the collective energy and commitment of the malaria communities across the world in uniting for the common objective of freeing the world from malaria.

For sample pages and special offers, please visit https://www.thinkingcapsrc.com/reports/1599/malaria-treatment-market

In 2016, India introduced its first National Framework for Malaria Elimination, which will be valid from 2016 through 2030. In 2019, the Indian government raised funding by more than 25% for the National Vector Borne Disease Control Programme, launched in 2003. The country has also increased its contribution as a donor to the Global Fund to Fight Malaria. Further, in the US, efforts for controlling malaria are made primarily through the President's Malaria Initiative (PMI), overseen by the US Global Malaria Coordinator. According to the Global Health Policy, the US planned the funding of ~US$ 1 billion in FY 2022 for malaria control and research activities. The goal of the US government under the PMI Strategy 2021-2026 is to manage malaria and reduce deaths caused by it, along with a long-term aim of eradicating the disease.

For sample pages and special offers, please visit https://www.thinkingcapsrc.com/reports/1599/malaria-treatment-market

Several governments of various countries across the globe are taking initiatives to create awareness and conduct research for the development of new antimalarial drugs and vaccines. As per the WHO data, total funding for the control and elimination of malaria reached ~US$ 3 billion in 2019; governments of endemic countries, collectively, contributed 31% (~US$ 900 million) of the total fund to create awareness and development of new vaccines. Private companies are also engaging in the fight against malaria and investing heavily in R&D activities. For instance, in 2018, Novartis invested more than US$ 100 million to enhance its research and development activities for next-generation treatments by 2023.

For sample pages and special offers, please visit https://www.thinkingcapsrc.com/reports/1599/malaria-treatment-market

Governments in countries with a high prevalence of malaria are deploying various strategies to eradicate the disease by improving access to treatment and helping communities in malaria-endemic countries in delivering better healthcare. A few of these initiatives are mentioned below.

For sample pages and special offers, please visit https://www.thinkingcapsrc.com/reports/1599/malaria-treatment-market

• Myanmar has a national malaria control plan that is approved by the Global Fund, and it expects to eliminate the disease caused by P. falciparum by 2030. The universal healthcare coverage in the country includes access to malaria diagnosis by microscopy or rapid diagnostic tests (RDTs) and the availability of artemisinin-based combination therapies (ACTs).
• Thailand has implemented the National Strategic Plan for Malaria Elimination that applies an integrated elimination strategy for the elimination of the disease by 2024.
• In January 2020, the Corporate Alliance on Malaria in Africa (CAMA) launched a strategic plan for 2021-2023. This plan aims to reach millions of people with malaria control interventions and scale up prevention activities in the region.
• Abbott collaborated with "Malaria No More" (a nonprofit organization to eradicate malaria) and the Government of Odisha, India, to provide technology, expertise, and funding to facilitate advanced efforts to end malaria in the state. In January 2019, Abbott announced its plans to supply one million RDTs to strengthen Odisha's malaria diagnosis and surveillance system. The company also announced its plans to support "Malaria No More" with the financial aid of US$ 750,000 to support the malaria elimination strategy in the state.

For sample pages and special offers, please visit https://www.thinkingcapsrc.com/reports/1599/malaria-treatment-market

Such initiatives by government and private companies to spread awareness about malaria and reinforce malaria eradication efforts are bolstering the malaria treatment market growth.

For sample pages and special offers, please visit https://www.thinkingcapsrc.com/reports/1599/malaria-treatment-market

Impact of COVID-19 on Malaria Treatment Market

According to the World Health Organization (WHO) report, there were an estimated 241 million cases of malaria and 627,000 malarial deaths globally in 2020. Additionally, two-thirds of these additional deaths (47,000) were linked to disruptions in the provision of malaria prevention, diagnosis, and treatment during the COVID-19 pandemic. Also, during the initial days of the pandemic, severe service disruptions caused malarial deaths in Sub-Saharan Africa. As Sub-Saharan Africa continues to carry the heaviest malaria burden accounting for ~95% of all malaria cases and 96% of all deaths in 2020 as per the estimates provided by WHO. Therefore, WHO and its partners recognize the need to ensure better and more equitable access to all health services involving malaria prevention, diagnosis, and treatment. Moreover, innovative tools also played a vital role in the treatment of malaria during the pandemic. For example, ""RTS,S/AS01 (RTS,S)"" is a new malaria prevention tool. Further, the WHO recommended that children living in Sub-Saharan Africa must be screened for moderate to high infection of P. falciparum.

For sample pages and special offers, please visit https://www.thinkingcapsrc.com/reports/1599/malaria-treatment-market

Rapid Diagnostic Tests (RDTs) to Bolster Malaria Treatment Market Growth

RDTs for malaria can improve the quality of management of the disease. RDTs are proven to be highly affordable and effective for public health programs implemented in low-resource settings. RDTs are widely used in remote areas with limited access to microscopy services. As a result, there has been a rapid rise in the demand for RDTs for malaria. Several RDTs have been developed to test the presence of malaria parasites in blood samples. Identifying and successfully treating malaria in low transmission areas is critical to reduce transmission and achieve complete elimination of the disease. According to the WHO, more than 70% of malaria diagnostic testing is performed using RDTs in Africa. Many companies are engaged in developing a wide range of RDTs with high sensitivities. A few of these developments are mentioned below.

For sample pages and special offers, please visit https://www.thinkingcapsrc.com/reports/1599/malaria-treatment-market

• In November 2020, researchers from Rice University developed a simple microneedle patch similar to a bandage to detect malaria. With this development, the researchers have stepped on the path of reducing the burden of disease in countries struggling with poor health infrastructure. The microneedles loaded on the patch collect interstitial fluid, which contains several biomarkers that help in detecting malaria.
• In June 2020, the Foundation for Innovative New Diagnostics (FIND) and Scanwell Health, a US-based company, partnered to develop a smartphone app that uses machine learning to read RDTs for malaria. This app would help healthcare professionals to interpret and record test results. With the expected compatibility with RDT kits and mobile devices, the app is likely to receive significant attention in low- and middle-income countries.

For sample pages and special offers, please visit https://www.thinkingcapsrc.com/reports/1599/malaria-treatment-market

Zydus Healthcare Ltd, Sun Pharmaceutical Industries Ltd, Sanofi SA, GSK Plc, Novartis AG, Cipla Ltd, Viatris Inc, Lupin Ltd, AdvaCare Pharma USA LLC, and VLP Therapeutics LLC are among the leading companies operating in the malaria treatment market.

For sample pages and special offers, please visit https://www.thinkingcapsrc.com/reports/1599/malaria-treatment-market

Based on treatment, the malaria treatment market is segmented into prescription medications, vaccines, diagnostic tests, and others. Based on drug type, the malaria treatment market is bifurcated into branded and generic. Based on route of administration, the malaria treatment market is bifurcated into oral and parenteral & intravenous. Based on distribution channel, the malaria treatment market is segmented into direct tender, hospital pharmacies, retail pharmacies, online pharmacies, and others. Based on end user, the malaria treatment market is segmented into hospitals, specialty clinics, homecare, and others. By geography, the malaria treatment market is segmented into North America (US, Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (UAE, Saudi Arabia, Africa, Nigeria, Democratic Republic of Congo, United Republic of Tanzania, Mozambique, Uganda, Ghana, Burkina Faso, Kenya, Zambia, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

For sample pages and special offers, please visit https://www.thinkingcapsrc.com/reports/1599/malaria-treatment-market

Thinking Caps Market Reports
Bangalore, India
Sayantan Paul
CEO and Founder
+1 800 257 6445
connect@thinkingcapsrc.com

Thinking Caps is a research powerhouse dedicated towards making your business decisions easier, faster and cost effective.

Equipped with a multi-publisher dynamic repository of readily available syndicate industry reports, Thinking Caps helps you maximize RoI through incisive insights, credible data analysis, updated company information, and the opportunity to expand your horizon through additional bespoke research. We help you take tangible decisions positively impacting your business growth.

This release was published on openPR.